Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Tango Therapeutics (TNGX) Profit After Tax: 2020-2025

Historic Profit After Tax for Tango Therapeutics (TNGX) over the last 6 years, with Sep 2025 value amounting to $15.9 million.

  • Tango Therapeutics' Profit After Tax rose 154.46% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.5 million, marking a year-over-year increase of 18.54%. This contributed to the annual value of -$130.3 million for FY2024, which is 28.07% down from last year.
  • As of Q3 2025, Tango Therapeutics' Profit After Tax stood at $15.9 million, which was up 140.88% from -$38.9 million recorded in Q2 2025.
  • Over the past 5 years, Tango Therapeutics' Profit After Tax peaked at $15.9 million during Q3 2025, and registered a low of -$39.9 million during Q1 2025.
  • In the last 3 years, Tango Therapeutics' Profit After Tax had a median value of -$29.2 million in 2024 and averaged -$26.8 million.
  • In the last 5 years, Tango Therapeutics' Profit After Tax plummeted by 951,806.78% in 2021 and then soared by 154.46% in 2025.
  • Tango Therapeutics' Profit After Tax (Quarterly) stood at -$22.0 million in 2021, then plummeted by 31.82% to -$29.1 million in 2022, then dropped by 5.86% to -$30.8 million in 2023, then dropped by 22.45% to -$37.7 million in 2024, then spiked by 154.46% to $15.9 million in 2025.
  • Its last three reported values are $15.9 million in Q3 2025, -$38.9 million for Q2 2025, and -$39.9 million during Q1 2025.